Profile banner
Xavier M. Segel

Xavier M. Segel

Co-founder & CEO at Taxa Technologies, engineering the human microbiome

xavier-segel
San Francisco Bay Area, California
Joined January 2025
Favicon imagelinkedin.com
Favicon imagetaxatech.com

Network

975 connections
💰
Venture Investors
⚙️
Startup Operations
🧪
Synthetic Biologists
⚖️
Biotech Legal Counsel
🧬
Biotech Founders
🎨
Creative Brand Strategy
🌿
Taxa Team

Summary

Xavier is a co-founder and CEO of Taxa Technologies, a synthetic biology startup focused on engineering the human microbiome. He successfully led the company through an oversubscribed $2.5M pre-seed funding round, demonstrating early entrepreneurial success in a cutting-edge field. taxatech+2
With Highest Honors in Biology from Williams College, Xavier has a strong academic background in genetics and molecular biology. He co-authored multiple scientific papers, including research on Drosophila eye color mutations and gene mapping, showcasing his expertise in biological research. nih+3
Xavier demonstrated early innovative spirit and engineering aptitude through his high school project, 'Edible Soft Robotic Candy Actuators.' This project won a Harvard University-hosted design competition, highlighting his ability to apply scientific principles to creative and practical applications. cambridge

Work

Education

Projects

Writing

purpleoid 1 , a classic Drosophila eye color mutation, is an allele of the t-SNARE-encoding gene SNAP29

April 1, 2025

Identified a missense mutation in SNAP29 responsible for the Drosophila eye color trait purpleoid (pd1) using complementation tests, genetic rescue, and DNA sequencing.

Favicon imagepubmed.ncbi.nlm.nih.gov

Mapping a Mutation to its Gene: The "Fly Lab" as a Modern Research Experience

January 1, 2020

Explores how a 'fly lab' approach using Drosophila melanogaster can serve as a modern research experience for genetics students, focusing on mapping mutations to genes.

Favicon imageresearchgate.net